Back to Market Feed

PRADAXA 110 MG CAPSULE

dabigatran etexilate mesylate
$3.1675per EA

Strength

110 mg/1

NDC

00597010854

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA022512

On Market Since

11/23/2015

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

+0.1%

6M

+0.2%

1Y

+0.1%

3Y

-59.9%

5Y

-58.4%

All

-47.0%

Generic Alternatives

1 alternative • Same active ingredient

PRADAXA 110 MG CAPSULE
Brand
00597010860•Boehringer Ingelheim Pharmaceuticals Inc.
$3.1675

Related Drugs

Same classification

No related drugs found.